Cronos Group Inc.

TSX:CRON.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$4.57 -0.27%

-$0.01 today

Market cap
$1.67B
Beta
1.25
P/E (TTM)
-488.1
EPS (TTM)
-$0.01
52W Low $2.54High $4.66

Volume 0.15M

Average 0.19M

CRON.TO Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

Cronos Group Inc.TSX: CRON.TO

Income Tax Expense · Q1 FY2026 · quarter ended Mar 2026

Income tax expense turns positive

Q1 FY2026 income tax expense was $2.39M, compared with -$456.25K a year earlier. Trailing-twelve-month income tax expense was -$11.53M.

Context

  • Income tax expense amounted to 9.7% of revenue in FY2025, up 6.8 pp from a year earlier.
  • Income tax expense increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly income tax expense holds near $2.39M or moves back toward the trailing-twelve-month quarterly average of -$2.88M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.39M+119.8% QoQ
Last fiscal yearDec 2025
-$14.44M-320.2% YoY
LTMMar 2026
-$11.53M-245.8% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+623.4%——
1 year-320.2%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Tax Expense history

USD · from the income statement

Latest · FY2025
(14.44M) USD
Year-over-year change
-320.2%

Income Tax Expense vs competitors

How CRON.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so income tax expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -245.8% is the 5th highest of 6, against a peer median of +35.2%.
  • Income tax expense amounts to 7.2% of revenue for CRON.TO, versus a peer median of 1.4%.
CRON.TO Competitors
Income Tax Expense for CRON.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EXE.TOExtendicare Inc.LTM Jun 2026CA$35.87M CAD+35.2%+1206.4%1.8%
SIA.TOSienna Senior Living Inc.LTM Sep 2026CA$16.1M CAD+3.7%+223.4%1.4%
GUD.TOKnight Therapeutics Inc.LTM Mar 2026CA$2.27M CAD+200.1%—0.4%
WELL.TOWELL Health Technologies Corp.LTM Mar 2026CA$619K CAD+102.9%—0.0%
CRON.TOCronos Group Inc.LTM Mar 2026-$11.53M USD-245.8%—7.2%
TLRY.TOTilray Brands, Inc.LTM Feb 2026-$121.91M USD-418.7%—14.2%
Peer median (excluding CRON.TO) —+35.2%+714.9%1.4%

Competitors are the stored peer set for CRON.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue64.02M87.54M87.03M117.5M149.15M
Cost of Revenue81.47M71.96M75.15M87.05M87.45M
Gross Profit(17.45M)15.58M11.88M30.45M61.7M
Gross Margin-27.3%17.8%13.7%25.9%41.4%
Research & Development21.66M13.25M5.83M4.22M4.53M
Selling, General & Admin120.67M101.64M80.74M76.74M75.01M
Operating Expenses272.09M128.01M96.48M106.91M79.54M
Depreciation & Amortization13.36M11.52M7.44M8.84M14.48M
EBITDA(150.79M)(93.81M)(72.28M)(45.37M)(2.94M)
EBITDA Margin-235.5%-107.2%-83.0%-38.6%-2.0%
Operating Income(289.54M)(112.44M)(84.6M)(76.46M)(17.84M)
Operating Margin-452.2%-128.4%-97.2%-65.1%-12.0%
Interest Income8.92M21.84M52.07M49.52M40.66M
Interest Expense00000
Other Income / Expenses162.1M(9.66M)11.1M113.01M419.21K
Income Before Tax(127.44M)(122.1M)(73.49M)36.55M(17.42M)
Pre-Tax Margin-199.1%-139.5%-84.4%31.1%-11.7%
Income Tax Expense(427.41K)34.48M(3.23M)(3.44M)(14.44M)
Net Income(392.81M)(170.26M)(73.79M)41.04M(9.61M)
Net Margin-613.5%-194.5%-84.8%34.9%-6.4%
EPS (Basic)(0.34)(0.42)(0.18)0.10(0.03)
EPS (Diluted)(0.34)(0.42)(0.18)0.10(0.03)
Weighted Avg Shares369.73M370.39M380.96M382.16M383.47M
Weighted Avg Shares (Diluted)370.39M370.39M380.96M382.16M383.47M

Cronos Group Inc.

TSX:CRON.TO

Intrinsic Alpha fair value

Locked

Current Price

$4.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.